Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

Clinical trial NCT01017536 · COMPLETED

Trial details

NCT number: NCT01017536
Sponsor: Aeras
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis HIV Infections

Start date: 2009-12-01
Primary completion: 2012-03-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.